Moreover, we demonstrated that increased ROR1-AS1 promotes the proliferation and migration of bladder cancer by sponging miR-504, and suggesting ROR1-AS1 may be used as a prognostic biomarker and therapeutic target for bladder cancer treatment. Here, ROR1 is linked to urinary bladder cancer.